FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3000344578> ?p ?o ?g. }

• W3000344578 abstract "Portal hypertension commonly accompanies advanced liver disease and often gives rise to life-threatening complications, including bleeding (haemorrhage) from oesophageal and gastrointestinal varices. Variceal bleeding commonly occurs in children with chronic liver disease or portal vein obstruction. Prevention is therefore important. Primary prophylaxis of variceal bleeding in adults is the established standard of care because of the results of numerous randomised clinical trials demonstrating the efficacy of non-selective beta-blockers or endoscopic variceal ligation in decreasing the incidence of variceal bleeding. However, sclerotherapy is the only endoscopic prophylactic option currently available in infants weighing less than 10 kg of bodyweight due to the size of the endoscopic ligator.To assess the benefits and harms of sclerotherapy versus any type of beta-blocker for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis.We searched The Cochrane Hepato-Biliary Group Controlled Trials Register, CENTRAL, PubMed, Embase Elsevier, LILACS (Bireme), and Science Citation Index Expanded (Web of Science) in February 2019. We scrutinised the reference lists of the retrieved publications and performed a manual search from the main paediatric gastroenterology and hepatology conferences (NASPGHAN and ESPGHAN) abstract books from January 2008 to December 2018. We searched ClinicalTrials.gov, FDA, EMA, and WHO, for ongoing clinical trials. There were no language or document type restrictions.We planned to include randomised clinical trials irrespective of blinding, language, or publication status, assessing sclerotherapy versus any type of beta-blocker for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis. We planned to include quasi-randomised and other observational studies retrieved with the searches for randomised clinical trials for report of harm.We planned to collect and summarise data from randomised clinical trials as described in our protocol, using standard Cochrane methodologies.We found no randomised clinical trials assessing sclerotherapy versus beta-blockers for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis.Randomised clinical trials assessing the benefits or harms of sclerotherapy versus beta-blockers for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis are lacking. Therefore, trials with adequate power and proper design, assessing the benefits and harms of sclerotherapy versus beta-blockers on patient-relevant clinical outcomes such as mortality, failure to control bleeding, and adverse events are needed. Unless such trials are conducted and the results become published, we cannot make any conclusions regarding the benefits or harms of the two interventions." @default.
• W3000344578 created "2020-01-23" @default.
• W3000344578 creator A5009947766 @default.
• W3000344578 creator A5026514859 @default.
• W3000344578 creator A5056811634 @default.
• W3000344578 creator A5054530074 @default.
• W3000344578 date "2020-01-10" @default.
• W3000344578 modified "2023-09-25" @default.
• W3000344578 title "Sclerotherapy versus beta-blockers for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis" @default.
• W3000344578 cites W1714980748 @default.
• W3000344578 cites W1896248585 @default.
• W3000344578 cites W1964489041 @default.
• W3000344578 cites W1964502734 @default.
• W3000344578 cites W1971062051 @default.
• W3000344578 cites W1971441597 @default.
• W3000344578 cites W1978363814 @default.
• W3000344578 cites W1993776960 @default.
• W3000344578 cites W1995932670 @default.
• W3000344578 cites W2011932878 @default.
• W3000344578 cites W2032323546 @default.
• W3000344578 cites W2033267170 @default.
• W3000344578 cites W2036654165 @default.
• W3000344578 cites W2041660740 @default.
• W3000344578 cites W2050302999 @default.
• W3000344578 cites W2055469806 @default.
• W3000344578 cites W2060123467 @default.
• W3000344578 cites W2065384164 @default.
• W3000344578 cites W2069243984 @default.
• W3000344578 cites W2069747045 @default.
• W3000344578 cites W2072416733 @default.
• W3000344578 cites W2084199501 @default.
• W3000344578 cites W2095367952 @default.
• W3000344578 cites W2096241342 @default.
• W3000344578 cites W2103194760 @default.
• W3000344578 cites W2117294447 @default.
• W3000344578 cites W2120536684 @default.
• W3000344578 cites W2124421980 @default.
• W3000344578 cites W2125435699 @default.
• W3000344578 cites W2134338262 @default.
• W3000344578 cites W2134829791 @default.
• W3000344578 cites W2155755597 @default.
• W3000344578 cites W2160795579 @default.
• W3000344578 cites W2171811563 @default.
• W3000344578 cites W2329288539 @default.
• W3000344578 cites W2412493681 @default.
• W3000344578 cites W2489987970 @default.
• W3000344578 cites W2519283785 @default.
• W3000344578 cites W2521332005 @default.
• W3000344578 cites W2526539531 @default.
• W3000344578 cites W2546046192 @default.
• W3000344578 cites W2547933991 @default.
• W3000344578 cites W2548923989 @default.
• W3000344578 cites W2591717879 @default.
• W3000344578 cites W2760567492 @default.
• W3000344578 cites W2767350488 @default.
• W3000344578 cites W2806212510 @default.
• W3000344578 cites W2810960624 @default.
• W3000344578 cites W2888027754 @default.
• W3000344578 cites W2899762109 @default.
• W3000344578 cites W2920870126 @default.
• W3000344578 cites W2927387493 @default.
• W3000344578 cites W2966058589 @default.
• W3000344578 cites W2975459328 @default.
• W3000344578 cites W3000344578 @default.
• W3000344578 cites W3009049240 @default.
• W3000344578 cites W3121809100 @default.
• W3000344578 cites W4210251857 @default.
• W3000344578 cites W4214559180 @default.
• W3000344578 cites W4238734568 @default.
• W3000344578 cites W800672599 @default.
• W3000344578 cites W2109908550 @default.
• W3000344578 doi "https://doi.org/10.1002/14651858.cd011659.pub2" @default.
• W3000344578 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6956467" @default.
• W3000344578 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31922266" @default.
• W3000344578 hasPublicationYear "2020" @default.
• W3000344578 type Work @default.
• W3000344578 sameAs 3000344578 @default.
• W3000344578 citedByCount "8" @default.
• W3000344578 countsByYear W30003445782019 @default.
• W3000344578 countsByYear W30003445782020 @default.
• W3000344578 countsByYear W30003445782021 @default.
• W3000344578 countsByYear W30003445782022 @default.
• W3000344578 crossrefType "journal-article" @default.
• W3000344578 hasAuthorship W3000344578A5009947766 @default.
• W3000344578 hasAuthorship W3000344578A5026514859 @default.
• W3000344578 hasAuthorship W3000344578A5054530074 @default.
• W3000344578 hasAuthorship W3000344578A5056811634 @default.
• W3000344578 hasBestOaLocation W30003445782 @default.
• W3000344578 hasConcept C126322002 @default.
• W3000344578 hasConcept C141071460 @default.
• W3000344578 hasConcept C2776848118 @default.
• W3000344578 hasConcept C2777075537 @default.
• W3000344578 hasConcept C2777214474 @default.
• W3000344578 hasConcept C2778012290 @default.
• W3000344578 hasConcept C2778230777 @default.
• W3000344578 hasConcept C2778800853 @default.
• W3000344578 hasConcept C2778808290 @default.
• W3000344578 hasConcept C2779102576 @default.
• W3000344578 hasConcept C2780868729 @default.
• W3000344578 hasConcept C41260117 @default.

• next